Cargando…

The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States

INTRODUCTION: Subdural hematoma (SDH) is a well described risk factor in the development of Status Epilepticus (SE), however the epidemiology of SE after SDH is unknown. In this study, we sought to determine the epidemiology of SE, the prevalence of risk factors, and impact on hospital mortality usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Seifi, Ali, Asadi-Pooya, Ali Akbar, Carr, Kevin, Maltenfort, Mitchell, Emami, Mehrdad, Bell, Rodney, Moussouttas, Michael, Yazbeck, Moussa, Rincon, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112038/
https://www.ncbi.nlm.nih.gov/pubmed/25077058
http://dx.doi.org/10.1186/2193-1801-3-332
_version_ 1782328149336391680
author Seifi, Ali
Asadi-Pooya, Ali Akbar
Carr, Kevin
Maltenfort, Mitchell
Emami, Mehrdad
Bell, Rodney
Moussouttas, Michael
Yazbeck, Moussa
Rincon, Fred
author_facet Seifi, Ali
Asadi-Pooya, Ali Akbar
Carr, Kevin
Maltenfort, Mitchell
Emami, Mehrdad
Bell, Rodney
Moussouttas, Michael
Yazbeck, Moussa
Rincon, Fred
author_sort Seifi, Ali
collection PubMed
description INTRODUCTION: Subdural hematoma (SDH) is a well described risk factor in the development of Status Epilepticus (SE), however the epidemiology of SE after SDH is unknown. In this study, we sought to determine the epidemiology of SE, the prevalence of risk factors, and impact on hospital mortality using a large administrative dataset. METHODS: Data was derived from the Nationwide Inpatient Sample from 1988 through 2011. We queried the NIS database for patients older than 18 years, with a diagnosis of SDH and SE. Diagnoses were defined by ICD 9 CM codes 432.1, 852.2, 852.3 and 345.3 for SE. Adjusted incidence rates of admission and prevalence proportions were calculated. Multivariate logistic models were then fitted to assess for the impact of status epilepticus on hospital mortality. RESULTS: Over the 23-year period, we identified more than 1,583,255 admissions with a diagnosis of SDH. The prevalence of SE in this cohort was 0.5% (7,421 admissions). The population adjusted incidence rate of admissions of SDH increased from 13/100,000 in 1988 to 38/100,000 in 2011. The prevalence of SE in SDH, increased from 0.5% in 1988 to 0.7% in 2011. In hospital mortality of patients with SDH and without SE decreased from 17.9% to 10.3% while in hospital mortality of patients with SDH and SE did not statistically change. Mortality increased over the same period (2.3/100,000 in 1988 to 3.9/100.000 in 2011) and the diagnosis of SE increased mortality in this cohort (OR 2.17, p < 0.0001). The risk of SE remained stable throughout the study period, but was higher among older patients, blacks, and in those with respiratory, metabolic, hematological, and renal system dysfunction. CONCLUSION: Our study demonstrates that the incidence of admissions of SDH is increasing in the United States. Despite a decline in the overall SDH related mortality, SE increased the risk of in-hospital death in patients with a primary diagnosis of SDH.
format Online
Article
Text
id pubmed-4112038
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-41120382014-07-30 The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States Seifi, Ali Asadi-Pooya, Ali Akbar Carr, Kevin Maltenfort, Mitchell Emami, Mehrdad Bell, Rodney Moussouttas, Michael Yazbeck, Moussa Rincon, Fred Springerplus Research INTRODUCTION: Subdural hematoma (SDH) is a well described risk factor in the development of Status Epilepticus (SE), however the epidemiology of SE after SDH is unknown. In this study, we sought to determine the epidemiology of SE, the prevalence of risk factors, and impact on hospital mortality using a large administrative dataset. METHODS: Data was derived from the Nationwide Inpatient Sample from 1988 through 2011. We queried the NIS database for patients older than 18 years, with a diagnosis of SDH and SE. Diagnoses were defined by ICD 9 CM codes 432.1, 852.2, 852.3 and 345.3 for SE. Adjusted incidence rates of admission and prevalence proportions were calculated. Multivariate logistic models were then fitted to assess for the impact of status epilepticus on hospital mortality. RESULTS: Over the 23-year period, we identified more than 1,583,255 admissions with a diagnosis of SDH. The prevalence of SE in this cohort was 0.5% (7,421 admissions). The population adjusted incidence rate of admissions of SDH increased from 13/100,000 in 1988 to 38/100,000 in 2011. The prevalence of SE in SDH, increased from 0.5% in 1988 to 0.7% in 2011. In hospital mortality of patients with SDH and without SE decreased from 17.9% to 10.3% while in hospital mortality of patients with SDH and SE did not statistically change. Mortality increased over the same period (2.3/100,000 in 1988 to 3.9/100.000 in 2011) and the diagnosis of SE increased mortality in this cohort (OR 2.17, p < 0.0001). The risk of SE remained stable throughout the study period, but was higher among older patients, blacks, and in those with respiratory, metabolic, hematological, and renal system dysfunction. CONCLUSION: Our study demonstrates that the incidence of admissions of SDH is increasing in the United States. Despite a decline in the overall SDH related mortality, SE increased the risk of in-hospital death in patients with a primary diagnosis of SDH. Springer International Publishing 2014-07-01 /pmc/articles/PMC4112038/ /pubmed/25077058 http://dx.doi.org/10.1186/2193-1801-3-332 Text en © Seifi et al.; licensee Springer. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Seifi, Ali
Asadi-Pooya, Ali Akbar
Carr, Kevin
Maltenfort, Mitchell
Emami, Mehrdad
Bell, Rodney
Moussouttas, Michael
Yazbeck, Moussa
Rincon, Fred
The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States
title The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States
title_full The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States
title_fullStr The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States
title_full_unstemmed The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States
title_short The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States
title_sort epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the united states
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112038/
https://www.ncbi.nlm.nih.gov/pubmed/25077058
http://dx.doi.org/10.1186/2193-1801-3-332
work_keys_str_mv AT seifiali theepidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT asadipooyaaliakbar theepidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT carrkevin theepidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT maltenfortmitchell theepidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT emamimehrdad theepidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT bellrodney theepidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT moussouttasmichael theepidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT yazbeckmoussa theepidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT rinconfred theepidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT seifiali epidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT asadipooyaaliakbar epidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT carrkevin epidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT maltenfortmitchell epidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT emamimehrdad epidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT bellrodney epidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT moussouttasmichael epidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT yazbeckmoussa epidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates
AT rinconfred epidemiologyriskfactorsandimpactonhospitalmortalityofstatusepilepticusaftersubduralhematomaintheunitedstates